National Institute on Drug Abuse International Program, U.S. Department of Health and Human Services, National Institutes of Health, Bethesda, MD, USA.
IQ Solutions, Inc, Rockville, MD, USA.
Subst Abus. 2021;42(4):397-406. doi: 10.1080/08897077.2021.1975874. Epub 2021 Oct 1.
As of April 2020, 121 individuals from 47 nations had completed 124 NIDA International Program INVEST Drug Abuse Research Fellowships. This is the first comprehensive effort to assess the fellowships from the combined perspectives of career outcomes, migration patterns, publications, cost per publication, and funding. We searched electronic sources such as university websites, ResearchGate, LinkedIn, PubMed, and NIH databases to find current curriculum vitae, journal articles published in 2018 and 2019, and funding records. We found electronic records for 94.2% of former NIDA INVEST fellows ( = 114); 55.5% were male ( = 67). The majority are at least partially involved in addiction research, prevention, or treatment (85.9%; = 98), primarily at academic institutions (73.7%, = 84) as faculty members (65.8%, = 75) conducting research (86%, = 98). Nearly three-fourths (74.6%, = 85) are still working in their home countries; and 74.6% ( = 85) coauthored at least one research article indexed in PubMed during 2018 or 2019. Of the 656 unique research articles, 52.4% ( = 344) were published by multinational groups. The average cost to NIDA for each peer-reviewed publication was $19,677. More than half (53.5%, = 61) of the fellows received funding through 431 unique grants-led by NIDA (55), other NIH Institutes and Centers (57) and other U.S. funders (55). Using the measures of career outcomes, migration patterns, publications, cost per publication, and funding INVEST fellowships are cost-effective mechanisms to advance scientific knowledge, build addiction research capacity, foster international cooperation, and promote adoption of evidence-based addiction policies and interventions around the world.
截至 2020 年 4 月，来自 47 个国家的 121 人完成了 124 项 NIDA 国际计划 INVEST 药物滥用研究研究员奖学金。这是首次从职业成果、移民模式、出版物、每篇出版物的成本和资金等综合角度评估奖学金。我们搜索了大学网站、ResearchGate、LinkedIn、PubMed 和 NIH 数据库等电子资源，以查找当前的简历、2018 年和 2019 年发表的期刊文章以及资金记录。我们找到了前 NIDA INVEST 研究员的 94.2%的电子记录（ = 114）；55.5%是男性（ = 67）。大多数人至少部分参与了成瘾研究、预防或治疗（85.9%； = 98），主要在学术机构（73.7%， = 84）担任教职（65.8%， = 75）进行研究（86%， = 98）。近四分之三（74.6%， = 85）仍在其原籍国工作；并且 74.6%（ = 85）在 2018 年或 2019 年共同撰写了至少一篇在 PubMed 中索引的研究文章。在 656 篇独特的研究文章中，52.4%（ = 344）是由跨国团体发表的。NIDA 每篇经过同行评审的出版物的平均成本为 19,677 美元。超过一半（53.5%， = 61）的研究员通过 431 项独特的资助获得了资金-NIDA（55）、其他 NIH 机构和中心（57）和其他美国资助者（55）。使用职业成果、移民模式、出版物、每篇出版物的成本和资金等衡量标准，INVEST 研究员奖学金是一种具有成本效益的机制，可以促进科学知识的发展，建立成瘾研究能力，促进国际合作，并促进全球范围内采用循证成瘾政策和干预措施。
